Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Peter Whang

Orthopaedic Surgery New Haven, CT Medical Doctor

NPI 1457447468 CMS profile 293261

800 Howard Ave, Yale Physicians Bldg, New Haven, CT 06519

Open in the dashboard

General payments

$1,809,920

2,675 records reported · program years 2019–2025

Research payments

$2,400

Paid to them · 2 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$239,064 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Peter Whang of New Haven, CT is reported in the CMS Open Payments database as having received $1,809,920 across 2,675 general payments and $2,400 in research payments paid to them. Separately, studies naming them as principal investigator received $239,064 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $130,625 190
2025 Research $1,200 1
2024 General $203,655 270
2024 Research $1,200 1
2023 General $307,445 369
2022 General $385,057 624
2021 General $246,677 482
2020 General $203,371 388
2019 General $333,092 352

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Peter Whang
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Peter Whang were reported at $130,625. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Peter Whang Orthopaedic Surgery median Middle half National median
2019 $333,092 $644 $140–$2,844 $163
2020 $203,371 $312 $75–$1,860 $114
2021 $246,677 $520 $117–$2,495 $132
2022 $385,057 $598 $128–$2,731 $149
2023 $307,445 $461 $128–$2,264 $160
2024 $203,655 $497 $134–$2,475 $164
2025 $130,625 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. SI-BONE, Inc. $812,226 1,528 payments
  2. Orthofix Medical, Inc. $234,546 386 payments
  3. Medtronic, Inc. $146,435 153 payments
  4. Relievant Medsystems, Inc. $101,687 57 payments
  5. Bioventus LLC $92,427 127 payments
  6. Medtronic USA, Inc. $79,252 52 payments
  7. Stryker Corporation $74,767 107 payments
  8. Boston Scientific Corporation $62,873 76 payments
  9. Centinel Spine, LLC $42,826 24 payments
  10. OssDsign Incorporated $42,110 32 payments
  11. Other $120,770 133 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $1,342,957 759 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $228,332 68 payments
  3. Travel and Lodging $178,907 984 payments
  4. Food and Beverage $52,753 860 payments
  5. Compensation for serving as faculty or as a speaker for a medical education program $6,375 2 payments
  6. Gift $530 1 payment
  7. Entertainment $66 1 payment
Products named General payments · program years 2019–2025
  1. IFUSE IMPLANT $525,295 1,025 payments
  2. IFUSE IMPLANT SYSTEM sacroiliac joint dysfunction $168,612 250 payments
  3. IFUSE IMPLANT SYSTEM sacroiliac joint dysfunction $96,996 130 payments
  4. Cervical-Stim $86,935 154 payments
  5. Intracept $82,757 35 payments
  6. Spinal-Stim $74,200 97 payments
  7. Cervical-Stim Osteogenesis Stimulator $57,782 109 payments
  8. Bonescalpel $57,684 79 payments
  9. Spinal-Stim Osteogenesis Stimulator $57,494 105 payments
  10. INFUSE BONE GRAFT $52,016 43 payments
  11. Other $664,015 678 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Globus Medical, Inc. $2,400 2 payments

Billing to Medicare

Part B · data year 2024 · 18 billing codes

Paid by Medicare

$37,510

Medicare's payments for the services billed

Medicare patients

122

Average age 71

Services billed

251

67 women, 55 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 67%
Depression 29%
Diabetes 25%
Ischemic heart disease 25%
Cancer 23%
COPD 22%
Osteoporosis 20%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

2,677 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Connecticut

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record